BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36197788)

  • 1. Research progress in targeted therapies for gastric cancer.
    Ye M; Xiu LJ; Ji QQ; Zhang YC; Sun YW; Zhao Y; Wang D; Li YJ; Wang XW; Yue XQ; Sun DZ
    Int J Clin Pharmacol Ther; 2022 Dec; 60(12):509-514. PubMed ID: 36197788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapy for gastric cancer: Current status and future directions (Review).
    Yuan DD; Zhu ZX; Zhang X; Liu J
    Oncol Rep; 2016 Mar; 35(3):1245-54. PubMed ID: 26718131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Therapies in Advanced Gastric Cancer.
    Patel TH; Cecchini M
    Curr Treat Options Oncol; 2020 Jul; 21(9):70. PubMed ID: 32725377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in targeted therapy for gastric cancer based on tumor driver genes.
    Wu S; Xu P; Zhang F
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 53(1):73-83. PubMed ID: 38413217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of ramucirumab in combination with paclitaxel for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma.
    Garrido M
    Expert Rev Anticancer Ther; 2016 Oct; 16(10):1005-10. PubMed ID: 27582051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced gastric adenocarcinoma: optimizing therapy options.
    Mizrak Kaya D; Harada K; Shimodaira Y; Amlashi FG; Lin Q; Ajani JA
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):263-271. PubMed ID: 28094573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapies in gastric cancer and future perspectives.
    Yazici O; Sendur MA; Ozdemir N; Aksoy S
    World J Gastroenterol; 2016 Jan; 22(2):471-89. PubMed ID: 26811601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric Cancer: New Drugs - New Strategies.
    Schulte N; Ebert MP; Härtel N
    Gastrointest Tumors; 2014 May; 1(4):180-94. PubMed ID: 26674336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting receptor tyrosine kinases in gastric cancer.
    Morishita A; Gong J; Masaki T
    World J Gastroenterol; 2014 Apr; 20(16):4536-45. PubMed ID: 24782606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety.
    Narita Y; Muro K
    Expert Opin Drug Saf; 2017 Mar; 16(3):319-327. PubMed ID: 27976952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer.
    Roviello G; Ravelli A; Polom K; Petrioli R; Marano L; Marrelli D; Roviello F; Generali D
    Cancer Lett; 2016 Mar; 372(2):187-91. PubMed ID: 26797419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted and novel therapy in advanced gastric cancer.
    Selim JH; Shaheen S; Sheu WC; Hsueh CT
    Exp Hematol Oncol; 2019; 8():25. PubMed ID: 31632839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular-targeted therapy for chemotherapy-refractory gastric cancer: a case report and literature review.
    Kuo HY; Yeh KH
    Anticancer Res; 2014 Jul; 34(7):3695-9. PubMed ID: 24982389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line chemotherapy for patients with advanced gastric cancer.
    Takahari D
    Gastric Cancer; 2017 May; 20(3):395-406. PubMed ID: 28260227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy for upper gastrointestinal tract cancer: current and future prospects.
    Rosenbaum MW; Gonzalez RS
    Histopathology; 2021 Jan; 78(1):148-161. PubMed ID: 33382497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft models.
    Shu S; Yamashita-Kashima Y; Yanagisawa M; Nakanishi H; Kodera Y; Harada N; Yoshimura Y
    Anticancer Drugs; 2020 Mar; 31(3):241-250. PubMed ID: 31633500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ramucirumab for the treatment of gastric or gastro-esophageal junction cancer.
    Khan U; Shah MA
    Expert Opin Biol Ther; 2019 Nov; 19(11):1135-1141. PubMed ID: 31452409
    [No Abstract]   [Full Text] [Related]  

  • 18. Advancing pharmacological treatment options for advanced gastric cancer.
    Sudo K; Yamada Y
    Expert Opin Pharmacother; 2015; 16(15):2293-305. PubMed ID: 26359224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic therapy for esophagogastric cancer: targeted therapies.
    Lyons TG; Ku GY
    Chin Clin Oncol; 2017 Oct; 6(5):48. PubMed ID: 29129088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Molecular Targeted Therapy in Advanced Gastric Cancer: A Comprehensive Review of Therapeutic Mechanism, Clinical Trials, and Practical Application.
    Li K; Li J
    Gastroenterol Res Pract; 2016; 2016():4105615. PubMed ID: 26880889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.